8-K
Current Report
Aurinia Pharmaceuticals Inc. Filed Acc 0001628280-22-015026
Shareholder vote results
- Item 5.07 Submission of matters to a vote of security holders
From the SEC's structured data for this filing
Loading auph-20220517.htm…